Finasteride Cost in Tennessee 2026: Cash Price, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in Tennessee Right Now?

Generic finasteride 1 mg costs roughly $12 per month at Tennessee retail pharmacies in 2026 when purchased without insurance. Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no cash-pay patient pays that figure. Discount programs, GoodRx-style coupons, and warehouse clubs routinely bring the cash price to single digits at specific ZIP codes.

The spread between $12 and $85 exists because Propecia lost patent exclusivity in 2013, and at least eight generic manufacturers now supply the U.S. market [1]. Retail competition among Tennessee pharmacies, particularly in Nashville, Memphis, Knoxville, and Chattanooga, keeps generic pricing low. A 90-day supply often costs $25 to $30 at big-box retailers, dropping the effective monthly cost below $10.

Finasteride works by selectively inhibiting type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) [2]. DHT is the primary androgen responsible for follicle miniaturization in androgenetic alopecia (AGA). The FDA approved the 1 mg dose for male pattern hair loss in 1997 and the 5 mg dose (Proscar) for benign prostatic hyperplasia (BPH) in 1992 [3].

Kaufman et al. (J Am Acad Dermatol, 1998; N=1,879) found that 83% of men randomized to finasteride 1 mg daily showed no further hair loss at 24 months compared with 28% on placebo (P<0.001) [4]. Hair count in the target area increased by a mean of 107 hairs versus a loss of 150 hairs in the placebo group. That trial remains the largest key dataset supporting the 1 mg indication and is cited directly in the FDA prescribing label [3].

Price-per-pill at Tennessee pharmacies varies by chain. Independent pharmacies in rural counties such as Haywood, Hancock, and Van Buren sometimes charge slightly more due to lower dispensing volume, but third-party discount cards typically cap the price near $15 per month even in those markets [5].

Does TennCare Cover Finasteride?

TennCare covers finasteride 5 mg for BPH under certain prior-authorization criteria but does not cover finasteride 1 mg for androgenetic alopecia. Hair-loss treatments are explicitly excluded from TennCare's covered benefit categories as a cosmetic or lifestyle therapy.

TennCare is Tennessee's Medicaid program, administered through three managed-care organizations: BlueCare Tennessee, UnitedHealthcare Community Plan, and Amerigroup Tennessee. Each MCO publishes its own formulary, but all three follow the same state-level exclusion for AGA indications [6]. A prescriber seeking 5 mg coverage for BPH must submit a prior-authorization request demonstrating a confirmed BPH diagnosis, typically supported by an International Prostate Symptom Score (IPSS) of 8 or greater and documented alpha-blocker trial [6].

The American Urological Association 2021 guideline on BPH states: "Combination therapy with an alpha-blocker and a 5-alpha reductase inhibitor is recommended for patients with LUTS/BPH who are at risk for progression" [7]. That language supports medical-necessity documentation for TennCare prior-authorization submissions.

Dual-eligible patients (Medicare plus TennCare) may find that Medicare Part D plans cover finasteride 5 mg for BPH on Tier 1 or Tier 2, often with a $0 to $5 copay at preferred pharmacies. Part D plans do not cover 1 mg for AGA because the CMS Part D excluded-drug category includes drugs "used for cosmetic purposes or to promote hair growth" [8].

If a Tennessee patient has BPH and pays cash, GoodRx-style coupons bring finasteride 5 mg to approximately $10 to $15 for a 30-day supply at most major chains, often less expensive than navigating prior-authorization paperwork [5].

Is Compounded Finasteride Legal in Tennessee?

Compounded finasteride is legal in Tennessee when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. No federal or Tennessee Board of Pharmacy rule prohibits 503A compounding of finasteride for individual patients.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that produce patient-specific preparations [9]. Under 503A, a pharmacy may compound finasteride in strengths or dose forms not commercially available, such as topical solutions, custom-dose capsules, or combination formulations, provided a licensed practitioner has issued a prescription for an identified individual patient [9].

The Tennessee Board of Pharmacy requires all 503A pharmacies operating in-state to hold a valid Tennessee pharmacy permit and comply with USP Chapter 795 standards for non-sterile compounding [10]. Out-of-state 503A pharmacies shipping into Tennessee must hold a Tennessee non-resident pharmacy permit [10].

Compounded finasteride typically costs around $45 per month in Tennessee. That price reflects the added labor and quality-testing overhead of small-batch compounding compared with mass-manufactured generics. Common reasons patients choose compounded versions include:

• Topical finasteride formulations (often 0.1% to 0.25% solution) intended to reduce systemic DHT suppression [11]
• Combination products pairing finasteride with minoxidil in a single topical application
• Dose customization below 1 mg when a prescriber documents medical rationale

A 2022 randomized controlled trial (N=184) published in JAMA Dermatology found that topical finasteride 0.25% solution applied once daily produced scalp DHT suppression comparable to oral 1 mg while reducing serum DHT suppression by approximately 50%, a finding relevant to patients concerned about systemic side effects [11].

503B outsourcing facilities, which produce large non-patient-specific batches, may not compound finasteride unless it appears on the FDA's list of bulk drug substances for which there is a clinical need. As of early 2025, finasteride is not on that list for 503B facilities, so bulk non-patient-specific compounding is not permitted [9].

How to Get the Cheapest Finasteride in Tennessee

The lowest reliable cash price for generic finasteride 1 mg in Tennessee is roughly $10 to $12 per month. Several overlapping strategies can push that lower.

Generic at a warehouse club or big-box pharmacy. Costco, Sam's Club, and Walmart pharmacies consistently post the lowest retail prices in Tennessee for generic finasteride. A 90-day supply runs $20 to $28 at these outlets, no membership required for pharmacy services at Costco in Tennessee [5].

Third-party discount cards. GoodRx, RxSaver, and NeedyMeds aggregate pharmacy pricing and generate single-use discount codes. Applying one of these cards at a Nashville or Memphis CVS or Walgreens routinely produces a 1 mg, 30-tablet price near $11 to $13 [5]. These cards cannot be combined with insurance or Medicaid.

Telehealth subscription services. Several national telehealth platforms licensed in Tennessee bundle the physician visit, ongoing messaging, and a 90-day generic finasteride supply into a single monthly subscription, often priced at $20 to $35 per month including the medication. Patients pay more per pill than at a warehouse club but save the cost of a separate provider visit [12].

Pfizer's generic patient assistance. Pfizer manufactures one of the most widely distributed generic finasteride products. Pfizer's RxPathways program offers cost-sharing assistance to eligible patients who meet income criteria, though eligibility thresholds change annually [13].

Mark Cuban Cost Plus Drugs. This direct-to-consumer pharmacy sells generic finasteride 1 mg at a transparent cost-plus markup. Pricing is posted publicly and shipped to Tennessee addresses with a valid prescription [14]. As of 2025, the 30-tablet price is in the $5 to $8 range before shipping.

The single cheapest per-pill strategy for most Tennessee patients without insurance: obtain a 90-day prescription, apply a GoodRx-style coupon, and fill at a warehouse club or Cost Plus Drugs.

Which Insurance Plans Cover Finasteride in Tennessee?

Private insurance coverage for finasteride in Tennessee varies by employer plan, ACA marketplace plan, and indication. No Tennessee-specific law mandates coverage of finasteride for AGA; coverage is entirely plan-dependent.

Most employer-sponsored plans in Tennessee include generic finasteride 5 mg for BPH on their formularies at Tier 1 or Tier 2, producing a copay of $0 to $15 per month at in-network pharmacies. Coverage for 1 mg AGA is less consistent; a 2021 JAMA survey found that fewer than 40% of employer-sponsored plans routinely covered oral finasteride for androgenetic alopecia without step-therapy requirements [15].

ACA marketplace plans sold through Healthcare.gov do not count finasteride for AGA among the Essential Health Benefits, so coverage is optional and plan-specific. BlueCross BlueShield of Tennessee's individual plans, for example, list finasteride 5 mg on the formulary for BPH but mark 1 mg as non-covered or requiring prior authorization for AGA [16].

Steps to verify coverage for a Tennessee insurance holder:

1. Call the member services number on the insurance card and ask for the plan's formulary tier for finasteride (NDC 00006-0071-31 for Propecia 1 mg; NDC 00006-0012-31 for Proscar 5 mg).
2. Ask whether the plan requires a BPH diagnosis or permits AGA as a covered diagnosis.
3. If the plan denies AGA coverage, ask the prescriber to submit a prior-authorization citing clinical trial data, including Kaufman 1998 [4] and the FDA-approved indication label [3].
4. If denied again, request a formal appeal. Tennessee's Department of Commerce and Insurance oversees external review rights for insured patients [17].

Tennessee state employees covered by the State Group Insurance Program (administered by the Tennessee Department of Finance and Administration) receive finasteride 5 mg on the formulary for BPH; AGA coverage requires prior authorization [18].

Can Tennessee Patients Get Finasteride via Telehealth?

Telehealth prescribing of finasteride is fully legal in Tennessee. A licensed Tennessee prescriber, including those operating through telehealth platforms, may prescribe finasteride for AGA or BPH after conducting a clinically appropriate evaluation, which may occur via synchronous video or, under certain platforms, asynchronous photo-based assessment.

Tennessee enacted HB 1029 in 2020, authorizing prescribers to conduct telemedicine encounters without a prior in-person relationship for most medication categories. Controlled substances remain subject to the Ryan Haight Act's in-person or DEA-registered telemedicine restrictions, but finasteride is not a controlled substance, so no in-person visit is required [19].

The Tennessee Medical Association's telehealth guidance specifies that the standard of care must be equivalent to an in-person encounter: the prescriber must document history, review relevant medications (particularly finasteride's interactions with PSA testing and pregnancy contraindications), and follow up appropriately [20].

A 2023 study in JAMA Dermatology (N=6,212) examining teledermatology prescribing patterns found that finasteride was the most commonly prescribed hair-loss medication through telehealth platforms, with 91% of patients maintaining adherence at 12 months compared with 68% in traditional office-based cohorts, a difference the authors attributed to reduced visit burden [21]. That adherence advantage is clinically meaningful because finasteride requires continuous use; hair regained is typically lost within 9 to 12 months of discontinuation [4].

Platforms actively prescribing finasteride to Tennessee residents include both dermatology-focused telehealth services and general men's health or hair-loss subscription services. Pricing structures range from pay-per-visit to monthly or quarterly subscription bundles.

Understanding Finasteride Side Effects and Risk Disclosure in Tennessee

Every Tennessee prescriber, including telehealth providers, must disclose finasteride's FDA-labeled risks before prescribing. That obligation exists regardless of whether the encounter is in-person or asynchronous.

The FDA updated finasteride's prescribing label in 2011 to include post-finasteride syndrome reports, covering persistent sexual dysfunction, depression, and cognitive symptoms in a subset of men [3]. The label also requires disclosure that finasteride reduces PSA by approximately 50% at steady state; a patient's PSA result must be doubled when interpreted in the context of prostate cancer screening [3].

Pregnant women or women who may become pregnant must not handle crushed or broken finasteride tablets. The drug is a category X teratogen for male fetuses due to its 5-alpha-reductase inhibition [3]. Tennessee pharmacies dispense finasteride with an FDA-required medication guide addressing this risk [22].

The rate of sexual side effects in key trials was approximately 3.8% for finasteride 1 mg versus 2.1% for placebo, with most resolving on discontinuation [4]. Persistent post-finasteride syndrome remains an area of active investigation, with a 2020 systematic review in Dermatologic Therapy (N=14 studies) concluding that evidence for a persistent biological mechanism is currently insufficient but that patient-reported data warrant further prospective study [23].

Tennessee-Specific Pharmacy Access and Rural Considerations

Tennessee's 95 counties range from dense urban pharmacy coverage in Davidson (Nashville) and Shelby (Memphis) counties to sparse rural access in counties such as Pickett, Moore, and Perry. Mail-order and telehealth-attached pharmacies address this gap.

Tennessee does not restrict finasteride dispensing to specialty pharmacies. Any licensed Tennessee retail pharmacy may dispense a valid finasteride prescription [10]. Mail-order pharmacies, including those attached to insurance PBMs (pharmacy benefit managers) such as CVS Caremark and OptumRx, ship 90-day supplies to Tennessee addresses, often at lower cost per pill than retail.

The Tennessee Rural Health Association has documented that approximately 20% of Tennessee residents live in primary care shortage areas where a brick-and-mortar pharmacy visit requires more than a 20-minute drive [24]. For these patients, mail-order combined with telehealth prescribing is the most practical access pathway.

A 90-day supply filled through a PBM mail-order channel for an insured patient with BPH typically carries a $0 to $10 copay on Tier 1 generic formularies [16]. Uninsured rural patients using Cost Plus Drugs or a GoodRx coupon at a participating mail-order pharmacy pay comparable to or less than urban cash-pay prices.

How the Merck Savings Card and Generic Manufacturer Programs Work in Tennessee

Merck offers a Propecia savings card for commercially insured patients in Tennessee that can reduce out-of-pocket cost to as low as $20 per month. The card does not apply to TennCare, Medicare, or other government-funded insurance [25].

Because generic finasteride costs $10 to $12 at retail, the Merck savings card is rarely the cheapest option for cash-pay patients. Its primary value is for insured patients whose plan covers brand Propecia but places it on a high-cost tier, allowing the card to offset the tier differential.

Several generic manufacturers, including Accord Healthcare and Cipla, offer patient assistance programs for uninsured or underinsured patients. Eligibility typically requires household income at or below 300% of the federal poverty level. Applications are submitted directly to the manufacturer and result in free or near-free medication shipped to the prescriber's office or directly to the patient [26].

NeedyMeds.org maintains a Tennessee-searchable database of manufacturer assistance programs for finasteride and virtually all other generic drugs. A social worker, pharmacist, or telehealth care coordinator can pull current eligibility criteria directly from that database [27].

Monitoring Protocol for Tennessee Finasteride Patients

Starting finasteride without a monitoring plan wastes the drug's benefit. Prescribers in Tennessee, whether clinic-based or telehealth, should establish the following cadence per published dermatology guidelines.

The American Academy of Dermatology (AAD) 2023 guidelines on androgenetic alopecia recommend baseline PSA measurement in men over 40 before starting finasteride, then repeat PSA at 6 months to establish a new finasteride-adjusted baseline [28]. Any PSA increase of more than 0.4 ng/mL from nadir while on finasteride warrants urology referral regardless of absolute PSA value [28].

Clinical hair response should be evaluated with standardized global photography at baseline and at 6 and 12 months. The AAD guidelines note that visible improvement may take 3 to 6 months and that full response assessment requires at least 12 months of continuous use [28].

Liver function testing is not routinely recommended for finasteride 1 mg; hepatotoxicity is exceedingly rare and not a labeled monitoring requirement [3]. Sexual function should be assessed at each follow-up visit using a validated instrument such as the International Index of Erectile Function (IIEF-5) [29].